Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Oddone F, Kirwan J, Lopez-Lopez F, Zimina M, Fassari C, Holló G; VISIONARY Study Group. Oddone F, et al. Among authors: lopez lopez f. Adv Ther. 2022 Aug;39(8):3501-3521. doi: 10.1007/s12325-022-02166-6. Epub 2022 May 7. Adv Ther. 2022. PMID: 35524840 Free PMC article.
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.
Garcia-Medina JJ, Benitez-Del-Castillo J, Rodríguez-Agirretxe I, Lopez-Lopez F, Moreno-Valladares A; VISIONARY Study Group (Spain). Garcia-Medina JJ, et al. J Ocul Pharmacol Ther. 2022 Apr;38(3):252-260. doi: 10.1089/jop.2021.0099. Epub 2022 Feb 28. J Ocul Pharmacol Ther. 2022. PMID: 35230148 Free PMC article.
Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Oddone F, Kirwan J, Lopez-Lopez F, Zimina M, Fassari C, Holló G; VISIONARY Study Group. Oddone F, et al. Among authors: lopez lopez f. Adv Ther. 2022 Aug;39(8):3522-3523. doi: 10.1007/s12325-022-02210-5. Adv Ther. 2022. PMID: 35731341 Free PMC article. No abstract available.
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy.
Moll-Udina A, Miguel Escuder L, Hernanz I, Llorenç V, Fonollosa A, Cordero Coma M, Sainz de la Maza M, Espinosa G, González Guijarro JJ, Lopez Lopez F, Alba-Linero C, Hernández M, Martínez Costa L, Celdrán Vivancos D, Giralt L, Artaraz J, Soler Bartrina P, Jódar Márquez M, García de Vicuña R, Esquinas C, Adán A. Moll-Udina A, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1591-1598. doi: 10.1080/09273948.2020.1769139. Epub 2020 Jul 13. Ocul Immunol Inflamm. 2021. PMID: 32657649
Enzymatic vitreolysis.
Lopez-Lopez F, Rodriguez-Blanco M, Gómez-Ulla F, Marticorena J. Lopez-Lopez F, et al. Curr Diabetes Rev. 2009 Feb;5(1):57-62. doi: 10.2174/157339909787314220. Curr Diabetes Rev. 2009. PMID: 19199900 Review.
41 results